CBSA is hosting a Leadership Roundtable Dinner – this is an exclusive event and offers an opportunity to cultivate new connections and enjoy great conversation amongst Colorado’s life sciences leaders.

The upcoming discussion will highlight how Biodesix, a leading data and mission driven, patient-centric diagnostics company has strategically navigated continued growth and embraced innovative opportunities to advance its personalized diagnostics to transform the cancer standard of care.  Robin Cowie, Chief Financial Officer & Chief Compliance Officer at Biodesix, a Member of CBSA’s Board of Directors, will share the company’s unique plans to expand into a former retail building in Louisville, which will undergo extensive renovations and tenant improvements to build a state-of-the-art-laboratory.  She will also provide insights on how the company has ventured beyond standard convention to identify and capitalize on less-traveled funding pathways.  This dynamic relationship between creativity and opportunity highlights the importance of thinking outside the box, not only for fostering innovation, but also for successfully commercializing life-saving health technologies.

Featured Speaker

Robin Harper Cowie – Chief Financial Officer & Chief Compliance Officer at Biodesix, Inc., and Member of CBSA’s Board of Directors

Robin Harper Cowie has been with Biodesix since March 2011 and has served as Chief Financial Officer for Biodesix since April 2017. She brings a depth of experience to the leadership team with a long history with the company and deep expertise in finance, government policy, reimbursement, and operations. Along with this depth of experience, she brings a passion and personal mission to bring access to Biodesix diagnostic testing for every person who needs them.

Robin has been with Biodesix in multiple financial and reimbursement positions since March 2011, serving as Vice President of Finance from February 2016 to April 2017, Vice President of Reimbursement & Health Economics from February 2015 to February 2016, Senior Director of Reimbursement from January 2014 to February 2015, and Director of Reimbursement from March 2011 to January 2014.

Prior to joining Biodesix, Robin held a leadership role in payer and government relations at Precision Therapeutics, Inc. Robin’s background includes corporate finance, managed care and payer relations, government reimbursement and regulatory policy, legal affairs, health economics and outcomes research, analytics, customer service and billing operations. Additionally, she spent several years as a laboratory researcher at the University of Pittsburgh Medical Center researching migraine, epilepsy, and ALS. Robin holds a B.S. in Molecular Biology from the University of Pittsburgh, and an M.B.A. in Finance from the Joseph M. Katz Graduate School of Business from the University of Pittsburgh.

---

Space is limited. Reach out to Emily Martini, CBSA’s Vice President, Partnerships, if you are interested in attending or learning more.

Thank you to our event sponsors: